- Home
- FKWL vs RLMD Comparison
FKWL vs RLMD Comparison
Compare FKWL & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FKWL
- RLMD
- Stock Information
- Founded
- FKWL 1981
- RLMD 2004
- Country
- FKWL United States
- RLMD United States
- Employees
- FKWL N/A
- RLMD N/A
- Industry
- FKWL Telecommunications Equipment
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- FKWL Utilities
- RLMD Health Care
- Exchange
- FKWL Nasdaq
- RLMD Nasdaq
- Market Cap
- FKWL 45.8M
- RLMD 37.2M
- IPO Year
- FKWL 1996
- RLMD N/A
- Fundamental
- Price
- FKWL $4.08
- RLMD $1.56
- Analyst Decision
- FKWL
- RLMD Buy
- Analyst Count
- FKWL 0
- RLMD 3
- Target Price
- FKWL N/A
- RLMD $5.00
- AVG Volume (30 Days)
- FKWL 18.5K
- RLMD 1.6M
- Earning Date
- FKWL 09-29-2025
- RLMD 11-06-2025
- Dividend Yield
- FKWL N/A
- RLMD N/A
- EPS Growth
- FKWL N/A
- RLMD N/A
- EPS
- FKWL N/A
- RLMD N/A
- Revenue
- FKWL $45,276,495.00
- RLMD N/A
- Revenue This Year
- FKWL N/A
- RLMD N/A
- Revenue Next Year
- FKWL N/A
- RLMD N/A
- P/E Ratio
- FKWL N/A
- RLMD N/A
- Revenue Growth
- FKWL 8.62
- RLMD N/A
- 52 Week Low
- FKWL $3.67
- RLMD $0.24
- 52 Week High
- FKWL $7.45
- RLMD $3.98
- Technical
- Relative Strength Index (RSI)
- FKWL 48.46
- RLMD 78.33
- Support Level
- FKWL $4.01
- RLMD $1.13
- Resistance Level
- FKWL $4.62
- RLMD $1.69
- Average True Range (ATR)
- FKWL 0.16
- RLMD 0.21
- MACD
- FKWL -0.02
- RLMD 0.09
- Stochastic Oscillator
- FKWL 16.39
- RLMD 84.35
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.